XML 13 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Information (Schedule Of Condensed Consolidating Statement Of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net loss $ 16,441 $ (6,847)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Equity in earnings of subsidiaries     
Depreciation, depletion and amortization 38,886 13,812
Impairment of oil and gas properties 368 1,381
Deferred income taxes 9,822 (4,161)
Derivative instruments 18,586 31,666
Stock-based compensation expenses 1,591 527
Debt discount amortization and other 648 256
Working capital and other changes:    
Change in accounts receivable (26,038) (6,667)
Change in inventory (9,641) (37)
Change in prepaid expenses 31 479
Change in other current assets 483 (113)
Change in other assets   (3)
Change in accounts payable and accrued liabilities 10,775 (7,448)
Change in other current liabilities (188)  
Change in other liabilities 1,001  
Net cash provided by (used in) operating activities 62,765 22,845
Cash flows from investing activities:    
Capital expenditures (269,975) (91,126)
Derivative settlements (1,291) (512)
Purchases of short-term investments 0 (114,974)
Redemptions of short-term investments 19,994  
Advances to joint interest partners 655 885
Advances from joint interest partners 5,484 4,938
Net cash used in investing activities (245,133) (200,789)
Cash flows from financing activities:    
Proceeds from issuance of senior notes   400,000
Purchases of treasury stock (1,181) (559)
Debt issuance costs (25) (10,027)
Investment in / capital contributions from subsidiaries     
Net cash provided by (used in) financing activities (1,206) 389,414
Increase (decrease) in cash and cash equivalents (183,574) 211,470
Beginning of period 470,872 143,520
End of period 287,298 354,990
Parent/Issuer [Member]
   
Cash flows from operating activities:    
Net loss 16,441 (6,847)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Equity in earnings of subsidiaries (26,264) 3,170
Depreciation, depletion and amortization     
Impairment of oil and gas properties     
Deferred income taxes (5,863) (2,234)
Derivative instruments     
Stock-based compensation expenses 1,591 527
Debt discount amortization and other 480 188
Working capital and other changes:    
Change in accounts receivable     
Change in inventory     
Change in prepaid expenses 155 118
Change in other current assets 10 (113)
Change in accounts payable and accrued liabilities 904 5,681
Change in other current liabilities     
Change in other liabilities     
Net cash provided by (used in) operating activities (12,546) 490
Cash flows from investing activities:    
Capital expenditures     
Derivative settlements     
Purchases of short-term investments   (114,974)
Redemptions of short-term investments 19,994  
Advances to joint interest partners     
Advances from joint interest partners     
Net cash used in investing activities 19,994 (114,974)
Cash flows from financing activities:    
Proceeds from issuance of senior notes   400,000
Purchases of treasury stock (1,181) (559)
Debt issuance costs    (9,650)
Investment in / capital contributions from subsidiaries (156,315) (49,999)
Net cash provided by (used in) financing activities (157,496) 339,792
Increase (decrease) in cash and cash equivalents (150,048) 225,308
Beginning of period 443,482 119,940
End of period 293,434 345,248
Combined Guarantor Subsidiaries [Member]
   
Cash flows from operating activities:    
Net loss 26,264 (3,170)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Equity in earnings of subsidiaries     
Depreciation, depletion and amortization 38,886 13,812
Impairment of oil and gas properties 368 1,381
Deferred income taxes 15,685 (1,927)
Derivative instruments 18,586 31,666
Stock-based compensation expenses     
Debt discount amortization and other 168 68
Working capital and other changes:    
Change in accounts receivable (27,768) (7,550)
Change in inventory (9,641) (37)
Change in prepaid expenses (124) 361
Change in other current assets 473  
Change in other assets   (3)
Change in accounts payable and accrued liabilities 11,601 (12,246)
Change in other current liabilities (188)  
Change in other liabilities 1,001  
Net cash provided by (used in) operating activities 75,311 22,355
Cash flows from investing activities:    
Capital expenditures (269,975) (91,126)
Derivative settlements (1,291) (512)
Redemptions of short-term investments     
Advances to joint interest partners 655 885
Advances from joint interest partners 5,484 4,938
Net cash used in investing activities (265,127) (85,815)
Cash flows from financing activities:    
Purchases of treasury stock     
Debt issuance costs (25) (377)
Investment in / capital contributions from subsidiaries 156,315 49,999
Net cash provided by (used in) financing activities 156,290 49,622
Increase (decrease) in cash and cash equivalents (33,526) (13,838)
Beginning of period 27,390 23,580
End of period (6,136) 9,742
Intercompany Eliminations [Member]
   
Cash flows from operating activities:    
Net loss (26,264) 3,170
Adjustments to reconcile net loss to net cash provided by operating activities:    
Equity in earnings of subsidiaries 26,264 (3,170)
Depreciation, depletion and amortization     
Impairment of oil and gas properties     
Deferred income taxes     
Derivative instruments     
Stock-based compensation expenses     
Debt discount amortization and other     
Working capital and other changes:    
Change in accounts receivable 1,730 883
Change in inventory     
Change in prepaid expenses     
Change in other current assets     
Change in accounts payable and accrued liabilities (1,730) (883)
Change in other current liabilities     
Change in other liabilities     
Net cash provided by (used in) operating activities     
Cash flows from investing activities:    
Capital expenditures     
Derivative settlements     
Redemptions of short-term investments     
Advances to joint interest partners     
Advances from joint interest partners     
Net cash used in investing activities     
Cash flows from financing activities:    
Purchases of treasury stock     
Debt issuance costs     
Investment in / capital contributions from subsidiaries     
Net cash provided by (used in) financing activities     
Increase (decrease) in cash and cash equivalents     
Beginning of period     
End of period